Yes, hence my example of clinical trialists. Observationally... when NN's enter a field like this, they seem to grow in use, not shrink. There's an uncomfortab

Yes, hence my example of clinical trialists. Observationally... when NN's enter a field like this, they seem to grow in use, not shrink. There's an uncomfortable epistemological, and arguably Darwinian, counterpoint to rejecting blackboxes or mathematically unprincipled methods, particularly when their objective results are superior. So for many people who claim NN's can't be used, that's often from a subjective methodology preference, and modern history seems to be on the side of NNs. I dislike that's true of a leading method, but that's where a lot of modern modeling is.